Loading...
Rho kinase inhibitors for treatment of glaucoma
Affecting 60 million patients, glaucoma is the second leading cause of blindness worldwide. Despite the availability of multiple medical and surgical treatments with effective intraocular pressure lowering, many patients still progress to become visually handicapped from glaucoma due to therapeutic...
Saved in:
| Published in: | Expert Rev Ophthalmol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6319899/ https://ncbi.nlm.nih.gov/pubmed/30613208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/eop.11.65 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|